A gastric band is a form of weight loss surgery in which a silicone band is placed around the upper stomach to restrict food intake and promote a feeling of fullness. Also known as a laparoscopic adjustable gastric band (LAGB), it is one of several bariatric procedures available in the UK, though it is now performed less frequently on the NHS than sleeve gastrectomy or gastric bypass. This article explains how the gastric band works, who may be eligible, what the procedure involves, its risks and long-term considerations, and how it compares with other weight loss surgery options.

What Is a Gastric Band and How Does It Work?

A gastric band is a silicone ring placed laparoscopically around the upper stomach, creating a small pouch that restricts food intake through a purely mechanical mechanism. It is adjustable and reversible, but unlike bypass or sleeve procedures, it has minimal hormonal effect on appetite.

A gastric band — also known as a laparoscopic adjustable gastric band (LAGB) — is a type of weight loss (bariatric) surgery in which a silicone band is placed around the upper portion of the stomach. This creates a small pouch above the band, which holds only a limited amount of food before the sensation of fullness is reached. The procedure is performed laparoscopically (keyhole surgery), meaning it involves small incisions and generally carries a shorter recovery time than open surgery.

The mechanism of action is primarily restrictive: by narrowing the passage between the upper and lower stomach, the band slows the movement of food and reduces the volume a person can comfortably eat at one sitting. This is a mechanical effect; unlike sleeve gastrectomy or gastric bypass, the gastric band has minimal hormonal influence on appetite or metabolism. This helps patients feel full sooner and for longer, which — when combined with dietary changes — supports gradual weight loss.

One of the distinguishing features of the gastric band is that it is adjustable and reversible. The band is connected via a tube to a small port placed just beneath the skin. A trained clinician can inject saline into this port to tighten the band or remove saline to loosen it, allowing the restriction to be tailored to the individual's needs over time. Some centres use radiological guidance for adjustments when clinically indicated.

Unlike gastric bypass or sleeve gastrectomy, no part of the stomach or digestive tract is permanently removed or rerouted. However, it is important to understand that reversal requires a further surgical procedure and does not automatically restore prior anatomy, weight, or metabolic function. Removal is therefore not undertaken lightly and is not routinely recommended.

It should be noted that LAGB is now infrequently performed in UK NHS centres. Long-term data — including from the National Bariatric Surgery Registry (NBSR) — show higher rates of complications, band removal, and revision surgery compared with sleeve gastrectomy and gastric bypass. The decision to proceed with any bariatric procedure is made on an individual basis by a specialist multidisciplinary team (MDT).

Who Is Eligible for a Gastric Band on the NHS?

NHS eligibility follows NICE CG189, requiring a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant obesity-related condition, after non-surgical interventions have failed. Lower BMI thresholds apply for people of Asian family origin per NICE NG28.

Access to gastric band surgery on the NHS is guided by criteria set out by the National Institute for Health and Care Excellence (NICE). According to NICE guidelines (CG189), bariatric surgery — including gastric banding — may be considered for adults who meet the following criteria:

• BMI of 40 kg/m² or above, or

• BMI between 35–39.9 kg/m² with a significant obesity-related condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea

• All appropriate non-surgical measures (dietary intervention, physical activity, behavioural support) have been tried and have not achieved or maintained adequate clinically beneficial weight loss

• The individual is fit for anaesthesia and surgery

• The individual commits to long-term follow-up

NICE also recommends that people with a BMI of 30–34.9 kg/m² who have recent-onset type 2 diabetes may be considered for surgery in some circumstances. Additionally, surgery should be considered as a first-line option for adults with a BMI over 50 kg/m² where other interventions are unlikely to be effective.

Importantly, NICE NG28 (Type 2 diabetes in adults: management) recommends that lower BMI thresholds should be applied for people of Asian family origin, who may develop obesity-related conditions at a lower BMI. Clinicians should refer to NG28 for the specific thresholds applicable in this group.

In practice, referral typically follows a stepped pathway: a GP refers the patient to a Tier 3 specialist weight management service, where intensive non-surgical interventions are provided. If these are unsuccessful and the patient meets surgical criteria, referral is then made to a Tier 4 bariatric MDT — comprising a surgeon, dietitian, psychologist, and specialist nurse — for full assessment of medical, psychological, and nutritional suitability. Smoking cessation is usually required before surgery, and patients will be advised of this expectation early in the pathway.

NHS availability may vary by Integrated Care Board (ICB) area, though local criteria should align with NICE standards. Private treatment is also available for those who do not meet NHS thresholds or who prefer not to wait.

What to Expect Before, During and After the Procedure

Surgery takes 30–60 minutes under general anaesthesia, with most patients discharged within one to two days and returning to light activities within one to two weeks. A staged dietary progression and the first band adjustment occur in the weeks following surgery.

Before surgery, patients undergo a thorough assessment by a bariatric MDT. Pre-operative preparation typically includes a low-calorie or liver-shrinking diet (usually for two to four weeks) to reduce the size of the liver and make surgery safer. Patients will also receive guidance on stopping certain medications, fasting requirements, and what to expect during recovery. Smoking cessation will be required where applicable, and the surgical team will advise on DVT/PE prophylaxis measures.

During the procedure, the gastric band is inserted under general anaesthesia using laparoscopic (keyhole) techniques. The operation typically takes 30–60 minutes. Most patients are discharged within one to two days, though this varies depending on individual circumstances and the surgical centre.

After surgery, the recovery period is generally shorter than for more complex bariatric procedures. Most people return to light activities within one to two weeks, though strenuous exercise should be avoided for four to six weeks. In the immediate post-operative period, patients follow a staged dietary progression. The exact timings vary by centre and patients should follow the specific guidance provided by their MDT, but a typical progression is:

• Weeks 1–2: Fluids only

• Weeks 3–4: Pureed or soft foods

• Week 5 onwards: Gradual reintroduction of solid foods

The first band adjustment ('fill') is usually carried out four to six weeks after surgery, once initial healing has occurred, and should always be performed by a trained clinician. Subsequent adjustments are made based on weight loss progress and tolerance.

Red flags — seek urgent medical attention if you experience any of the following:

• Persistent vomiting or inability to keep fluids down

• Severe or worsening abdominal or chest pain

• Fever, rapid heart rate, or feeling generally unwell

• Breathlessness or calf pain or swelling (which may indicate a blood clot)

For urgent concerns, contact NHS 111 or attend your nearest A&E department. Call 999 immediately for severe chest pain, difficulty breathing, or collapse. Between appointments, patients should also contact their GP or surgical team promptly if they experience difficulty swallowing or any other concerning symptoms.

Risks, Complications and Long-Term Considerations

Long-term complications include band slippage, band erosion, port problems, and oesophageal dilatation, with a significantly higher reoperation rate than other bariatric procedures. Annual lifelong blood monitoring and daily nutritional supplementation are recommended.

As with any surgical procedure, gastric banding carries both short- and long-term risks. It is important that patients receive balanced information to make an informed decision in partnership with their clinical team.

Short-term risks include those associated with general anaesthesia and laparoscopic surgery, such as infection, bleeding, blood clots (deep vein thrombosis or pulmonary embolism), and injury to surrounding structures. These are relatively uncommon but require prompt medical attention if they occur.

Longer-term complications specific to gastric banding include:

• Band slippage — the stomach can slip through the band, causing obstruction or reflux

• Band erosion — the band gradually wears through the stomach wall (rare but serious); risk is increased by smoking and regular use of NSAIDs (anti-inflammatory painkillers). Patients should avoid smoking and seek MDT advice before using NSAIDs

• Port or tubing problems — leaks, flipping of the port, or infection at the port site

• Oesophageal dilatation — enlargement of the oesophagus due to chronic obstruction

• Inadequate weight loss or weight regain — particularly if dietary guidance is not followed

Gastric banding has a higher long-term reoperation rate compared with other bariatric procedures. UK data from the National Bariatric Surgery Registry (NBSR) confirm that a significant proportion of patients require band removal or revision surgery within ten years. This is one of the principal reasons why LAGB is now offered less frequently than sleeve gastrectomy or gastric bypass in UK NHS centres.

Nutritional considerations: Whilst nutritional deficiencies are less common with banding than with malabsorptive procedures, they can still occur. In line with guidance from the British Obesity and Metabolic Surgery Society (BOMSS), patients should take a daily multivitamin and mineral supplement and a calcium/vitamin D supplement as advised by their centre. At minimum, annual lifelong blood monitoring is recommended, including full blood count (FBC), urea and electrolytes (U&E), liver function tests (LFTs), ferritin, folate, vitamin B12, vitamin D (±PTH), and calcium. Additional tests may be indicated based on individual comorbidities.

Pregnancy: Women of childbearing age should avoid pregnancy for at least 12–18 months after surgery, when weight is still changing rapidly. The band may need to be deflated during pregnancy to ensure adequate nutrition — this should be coordinated with the bariatric MDT and obstetric team.

Reporting device problems: Gastric bands and their associated ports and tubing are regulated medical devices. If you or a healthcare professional suspect a problem related to the device itself, this should be reported to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk, in addition to informing the surgical team.

Gastric Band vs Other Weight Loss Surgery Options

Compared with sleeve gastrectomy and gastric bypass, the gastric band is adjustable and reversible but produces slower weight loss and carries a higher rate of long-term complications and revision surgery. Procedure choice should be made individually following MDT assessment per NICE CG189.

Gastric banding is one of several bariatric procedures available in the UK. Understanding how it compares to other options can help patients and clinicians make the most appropriate choice based on individual circumstances.

Sleeve gastrectomy involves the permanent removal of approximately 75–80% of the stomach, leaving a narrow sleeve-shaped pouch. It is both restrictive and hormonal in effect (reducing ghrelin, the hunger hormone), and typically produces greater and more sustained weight loss than a gastric band. It is currently one of the most commonly performed bariatric procedures in the UK.

Roux-en-Y gastric bypass (RYGB) combines restriction with malabsorption by creating a small stomach pouch and rerouting the small intestine. It is considered highly effective, particularly for people with type 2 diabetes, but is more complex and carries a higher risk of nutritional deficiencies requiring lifelong supplementation and monitoring.

One-anastomosis gastric bypass (OAGB), sometimes called a mini gastric bypass, is an established procedure offered at some UK centres. It involves a single join between the stomach pouch and the small intestine and has a similar nutritional risk profile to RYGB; patients considering this option should discuss the specific implications with their MDT.

Intragastric balloon is a non-surgical, temporary option where a saline-filled balloon is placed in the stomach endoscopically. Dwell time varies by device, typically ranging from 4 to 12 months. It is less invasive but produces more modest and less durable weight loss than surgical options.

In comparison, the gastric band offers the advantages of being adjustable, reversible, and less anatomically disruptive. However, it generally produces slower and less dramatic weight loss, requires ongoing adjustments by trained clinicians, and has a higher rate of long-term complications and revision surgery. NICE does not recommend one procedure over another universally; the choice should be made on an individual basis following MDT assessment, taking into account the patient's BMI, comorbidities, lifestyle, and personal preferences, in line with NICE CG189 and QS127.

Support, Follow-Up Care and Lifestyle Changes After Surgery

Long-term success depends on sustained dietary changes, regular physical activity, psychological support, and consistent engagement with bariatric follow-up, including at minimum annual blood tests. After at least two years of specialist Tier 4 follow-up, lifelong GP-led shared care is recommended.

Gastric band surgery is not a standalone solution — its success depends heavily on sustained lifestyle changes and consistent engagement with follow-up care. Patients who achieve the best long-term outcomes are those who view surgery as a tool to support, rather than replace, healthy behaviours.

Dietary changes are fundamental. Patients are advised to:

• Eat small, regular meals and chew food thoroughly

• Avoid drinking fluids with meals, as this can cause the pouch to empty too quickly

• Prioritise protein-rich foods and limit high-calorie, soft foods (such as ice cream or crisps) that can bypass the band's restriction

• Avoid carbonated drinks, which may cause discomfort and bloating

Nutritional supplementation: In line with BOMSS guidance, patients should take a daily multivitamin and mineral supplement and a calcium/vitamin D supplement as directed by their centre. Specific supplement requirements may vary; patients should follow their MDT's protocol.

Physical activity should be gradually increased following recovery. Regular moderate exercise — such as brisk walking, swimming, or cycling — supports weight loss, improves cardiovascular health, and helps preserve muscle mass during periods of caloric restriction.

Psychological support is an important component of post-operative care. Many patients benefit from ongoing counselling or support groups to address emotional eating, body image concerns, and the psychological adjustments that accompany significant weight loss.

Alcohol and smoking: Patients are advised to limit alcohol intake and to stop smoking. Smoking increases the risk of band erosion and other complications, and the surgical team will provide guidance on cessation support.

Pregnancy planning: Women should avoid pregnancy for at least 12–18 months after surgery. If pregnancy is planned or occurs, the bariatric MDT should be informed promptly, as band adjustment may be required.

Follow-up and monitoring: Appointments with the bariatric team are typically scheduled at regular intervals — commonly at six weeks, three months, six months, and annually thereafter. These allow for band adjustments, nutritional monitoring (including at minimum annual blood tests: FBC, U&E, LFTs, ferritin, folate, B12, vitamin D±PTH, and calcium), and assessment of overall progress. After the initial period of Tier 4 specialist follow-up (a minimum of two years, in line with NICE guidance), ongoing lifelong follow-up is recommended, typically transitioning to GP-led care with a clear shared-care plan. Patients should know how to re-access bariatric services if problems arise.

Patients should contact their GP or surgical team promptly if they experience any concerning symptoms between appointments, including persistent nausea, reflux, difficulty swallowing, or unexplained weight regain. For urgent symptoms, follow the red-flag guidance described in the section above.

Not sure if this is normal? Chat with one of our pharmacists →

Frequently Asked Questions